NOVA BIOMEDICAL

Company Snapshot

Founded: 1976
Entity Type: Private
Headquarter: U.S.
Key Geographics: North America, Europe, Russia, Eastern Europe, Africa, Asia, Latin America, Middle East
Corporate Address: 200 Prospect Street Waltham, Massachusetts U.S. 02454-9141 Tel: +1-781-894-0800 Web: www.novabiomedical.com

Company Overview

Nova Biomedical was founded in 1976 and is headquartered in Waltham, Mass. The company engages in the manufacture and marketing of a wide range of whole blood, point-of-care and critical care analyzers. The company's product line ranges from hospital point-of-care measuring systems and hospital blood gas analyzers to biotech chemistry or cell analyzers and self-testing diabetes monitoring systems, also providing the biotechnology industry with instruments for cell culture monitoring.

As of December 2022, the company had 63 patents and out of which 25 active patents 6 pending patents and 32 inactive patents.

NOVA BIOMEDICAL In Reports

Diagnostics and Therapeutics for HIV: Global Markets

BCC Research Market Report says global market for HIV diagnostics and therapeutics is expected to increase from $30.4 billion in 2023 to $39.3 billion by the end of 2028 with CAGR of 5.3%.

Global Markets for Diabetes Therapeutics and Diagnostics

BCC Market Research Report for Diabetes Therapeutics & Diagnostics provides a detailed review including diabetes medications, insulin delivery devices, monitoring devices, and insulin pumps.

Patient Monitoring Devices: Global Markets

BCC Research Market Analysis Report Says patient monitoring devices market should reach $42.7 bln by 2022 and more than $65.4 bln by 2027 with a CAGR of 8.9%.

NOVA BIOMEDICAL In News

Company's Business Segments

  • Blood Testing Analyzers : This segment provides critically ill and hospitalized patients with most expensive blood analyzing tests in a shorter time period.

Applications/End User Industries

  • Biotechnology
  • Healthcare